Iliesiu Andreea, Ungureanu Irena Antonia, Petca Aida, Constantin Maria Magdalena, Petca Razvan-Cosmin, Sandru Florica, Constantin Traian, Dumitrascu Mihai Cristian
Department of Pathology, University and Emergency Hospital, 014461 Bucharest, Romania.
Department 2 - Preclinical Sciences, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Exp Ther Med. 2020 Sep;20(3):2489-2492. doi: 10.3892/etm.2020.8805. Epub 2020 May 28.
The present study aims to raise awareness about the necessity of a thorough differential diagnosis process when diagnosing paraganglioma as it is an extremely rare entity with a high malignant potential. A 64-year-old female patient was admitted to the hospital with symptoms of bowel obstruction and a palpable abdominal mass. Abdominal and pelvic computed tomography revealed a cystic heterogeneously enhanced mass. The tumor was surgically removed and then microscopically analysed. Microscopically, the mass was composed of nests of small polygonal and round cells with central vesicular nuclei, consistent with the diagnosis of mesenteric paraganglioma which was later confirmed by immunohistochemistry. The critical markers for paragangliomas, namely chromogranin A and S100, should be used as the first step in diagnosis, followed by other valuable immunohistochemical markers. A long-term follow-up is extremely important following the diagnosis of paraganglioma as all these tumors have a malignant potential.
本研究旨在提高人们对诊断副神经节瘤时进行全面鉴别诊断过程必要性的认识,因为它是一种极为罕见且具有高恶性潜能的实体。一名64岁女性患者因肠梗阻症状和可触及的腹部肿块入院。腹部和盆腔计算机断层扫描显示一个囊性且强化不均匀的肿块。该肿瘤经手术切除,随后进行显微镜分析。显微镜下,肿块由小多边形和圆形细胞巢组成,细胞核呈中央空泡状,符合肠系膜副神经节瘤的诊断,后来经免疫组织化学证实。副神经节瘤的关键标志物,即嗜铬粒蛋白A和S100,应作为诊断的第一步,随后使用其他有价值的免疫组织化学标志物。诊断副神经节瘤后进行长期随访极为重要,因为所有这些肿瘤都有恶性潜能。